Literature DB >> 803524

Immunogenic properties of modified antigen E. II. Ability of urea-denatured antigen and alpha-polypeptide chain to prime T cells specific for antigen E.

K Ishizaka, H Okudaira, T P King.   

Abstract

Ragweed antigen E loses its major antigenic determinant after denaturation in 8 M urea. The urea-denatured (UD) antigen and alpha-polypeptide chain isolated from the denatured molecule possess their own antigenic determinant(s) but lack the major determinant of the native molecule. The UD antigen and alpha-chain, however, are capable of priming mouse T cells specific for antigen E. Priming of A/J mice with the modified antigen enhanced both IgG and IgE antibody responses to antigen E. Both UD antigen-primed spleen cells and alpha-chain-primed spleen cells collaborate with DNP-primed cells to give an adoptive secondary anti-DNP antibody response to DNP-ragweed antigen in syngeneic irradiated mice. Pretreatment of A/J mice with an i.v. injection of alpha-chain partially suppressed both IgE and IgG antibody responses to antigen E. Weekly injections of alpha-chain or UD antigen to antigen E-primed animals depressed on-going IgE antibody response, and suppressed secondary IgE antibody response to antigen E. Transfer of spleen cells from animals treated with the modified antigen to irradiated recipients followed by challenge with native antigen showed that the adoptive secondary response was suppressed by injections of modified antigen to the donors. The results indicate that the immunocompetent cell population was changed by the treatment and provide an experimental model to analyze the immunologic effect of hyposensitization treatment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 803524

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  The invariant chain forms complexes with class II major histocompatibility complex molecules and antigenic peptides "in vivo".

Authors:  M Viguier; K Dornmair; B R Clark; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  Hyposensitization therapy.

Authors:  A Leznoff
Journal:  Can Fam Physician       Date:  1987-02       Impact factor: 3.275

3.  Immunological properties of peptic fragments of bovine serum albumin.

Authors:  S Dosa; A J Pesce; D J Ford; A Muckerheide; J G Michael
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

4.  The rationale for immunotherapy in respiratory allergies.

Authors:  P S Norman
Journal:  Trans Am Clin Climatol Assoc       Date:  1978

5.  In vitro synthesis of IgE by human peripheral blood leucocytes. II modulation of IgE B cell activity by isotype-specific regulatory T cells.

Authors:  G H Holt; K J Turner; B J Holt
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

6.  Immunotherapy in respiratory allergy.

Authors:  R J Davies
Journal:  Thorax       Date:  1983-06       Impact factor: 9.139

Review 7.  Recent studies on the regulation of IgE antibody synthesis in experimental animals and man.

Authors:  D H Katz
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

Review 8.  Mechanisms of reaginic hypersensitivity and immunotherapy.

Authors:  K Ishizaka; T Ishizaka
Journal:  Lung       Date:  1978       Impact factor: 2.584

9.  Adjuvant and suppressive effects of Grass Conjuvac and other alginate conjugates on IgG and IgE antibody responses in mice.

Authors:  W A Taylor; D Sheldon; J W Spicer
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

10.  Effect of polyethyleneglycol (PEG) on spontaneous and polymyxin B-induced histamine release from rat peritoneal mast cells.

Authors:  K E Magnusson; I Svensson; B Gustavsson; L Enerbäck
Journal:  Cell Biophys       Date:  1982-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.